Sign up to save your podcasts
Or
Share Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)
Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Randomized, Vehicle- Controlled, Multicenter, Phase 3 Trial (Saturn-2)
Hosted by: Andrew Pucker, OD, PhD, FAAO
Topical Editor: Andrew Pucker, OD, PhD, FAAO
Topical Expert: Patrick Vollmer, OD, FAAO - Tarsus
Article: https://pubmed.ncbi.nlm.nih.gov/37285925/
View all episodes
By American Academy of Optometry Foundation
5
33 ratings
Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Randomized, Vehicle- Controlled, Multicenter, Phase 3 Trial (Saturn-2)
Hosted by: Andrew Pucker, OD, PhD, FAAO
Topical Editor: Andrew Pucker, OD, PhD, FAAO
Topical Expert: Patrick Vollmer, OD, FAAO - Tarsus
Article: https://pubmed.ncbi.nlm.nih.gov/37285925/
More shows like AAOF Clinical Podcast Series
View all
Power Hour Optometry
77 Listeners
Optometric Insights Media
21 Listeners
The 20/20 Podcast
8 Listeners